As of January 22, 2025, Ocuphire Pharma (OCUP) has a market cap of $31.737 million USD. According to our data, Ocuphire Pharma is ranked No.8384 in global market value.
Year | Market Cap | %Change |
---|---|---|
Dec 24, 2024 | $31.74 M |
-65.45%
|
Dec 29, 2023 | $78.86 M |
-14.73%
|
Dec 30, 2022 | $92.48 M |
-5.36%
|
Dec 31, 2021 | $97.72 M |
-42.53%
|
Dec 31, 2020 | $0.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Aldeyra Therapeutics
ALDX
|
$0.30 B |
-0.000 M
|
USA
|
Alimera Sciences
ALIM
|
$0.30 B |
0.000 M
|
USA
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Clearside Biomedical
CLSD
|
$72.42 M |
-0.000 M
|
USA
|
EyePoint Pharmaceuticals
EYPT
|
$0.60 B |
-0.000 M
|
USA
|
Kala Pharmaceuticals
KALA
|
$36.53 M |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Santen Pharmaceutical
4536.T
|
$3.40 B |
-0.013 B
|
Japan
|
Sun Pharmaceutical
SUNPHARMA.NS
|
$49.93 B |
1.006 B
|
India
|
Seabridge Gold
SA
|
$1.12 B |
0.000 M
|
Canada
|
Market Cap | = | OCUP Stock Price | * | OCUP Shares Outstanding |
= | $1.04 | * | 26.20 M | |
= | $31.74 M |